Health Catalyst (HCAT) Current Deferred Revenue (2018 - 2026)

Health Catalyst has reported Current Deferred Revenue for 9 years, with the latest figure at $69.7 million in Q1 2026.

• For the quarter ending Q1 2026, Current Deferred Revenue fell 3.01% year-over-year to $69.7 million; the trailing twelve-month figure through Mar 2026 stood at $69.7 million (down 3.01% YoY), and the FY2025 full-year result was $56.5 million, up 5.61% from the prior year.
• Current Deferred Revenue for Q1 2026 stood at $69.7 million, up from $56.5 million in the prior quarter.
• The five-year high for Current Deferred Revenue was $71.9 million in Q1 2025, with the low at $52.2 million in Q3 2024.
• Historically, Current Deferred Revenue has averaged $60.0 million across 5 years, with a median of $59.2 million in 2025.
• Annual changes were most pronounced in 2023 — Current Deferred Revenue decreased 5.82% — and 2025, when it advanced 19.42%.
• Health Catalyst's Current Deferred Revenue stood at $55.1 million in 2022, then climbed by 1.27% to $55.8 million in 2023, then dropped by 4.12% to $53.5 million in 2024, then advanced by 5.61% to $56.5 million in 2025, then rose by 23.43% to $69.7 million in 2026.
• The last three Current Deferred Revenue figures came in at $69.7 million (Q1 2026), $56.5 million (Q4 2025), and $59.2 million (Q3 2025), per Business Quant data.